Leeds Trust Trials Digital Diabetes Tools for Youth: Leeds 2026

Key Points

• UK Pilot Site Selected: Leeds Teaching Hospitals NHS Trust is chosen as the exclusive UK site for the five-year European IMPACT-MED research initiative.
• Target Demographic: Children, adolescents, and young adults with Type 1 diabetes across Yorkshire will test digital health innovations.
• Core Technologies: The project will evaluate remote monitoring platforms and personalized digital education tools to enhance clinical self-management.
• Collaborative Partnership: Leeds Children’s Hospital will work alongside industry partners Minimed-Diabeter and DigiBete.
• Broader Impact: The data collected will help assess how digital healthcare infrastructure can be scaled across different European healthcare settings.

Leeds (The Leeds Times) July 15, 2026, the launch of its localized pilot under the European IMPACT-MED initiative. The five-year project aims to transform traditional paediatric and young adult diabetes management by integrating hybrid care mechanisms, such as remote physiological tracking and interactive digital training.

By embedding these platforms directly into the ongoing treatment pathways of over 500 patients across Yorkshire, clinicians intend to gather critical data on how technical infrastructure can alleviate the clinical burden on the National Health Service (NHS) while improving long-term health outcomes for youth navigating chronic cardiometabolic conditions.

What is the IMPACT-MED Initiative and Who is Participating?

The Innovative Management and Predictive Analysis of Cardiometabolic Conditions Using Digital Technologies (IMPACT-MED) project is a comprehensive five-year initiative supported by the European Union’s Innovative Health Initiative Joint Undertaking (IHI JU).

The cross-border consortium brings together medical experts, academic researchers, medical technology manufacturers, and patient advocacy organisations across 13 countries to modernise care frameworks for various cardiometabolic illnesses.

The grand-scale project is co-led internationally by the Università Campus Bio-Medico di Roma in Italy and Medtronic Ibérica in Spain, managing a network of 26 distinct institutional partners.

Within this vast framework, Leeds Teaching Hospitals NHS Trust stands out as the only NHS entity selected to participate, providing a critical British framework to an otherwise mainland European study.

How Will Digital Tools Alter Care Delivery at Leeds Children’s Hospital?

Under the pilot framework, young patients being treated by the Children and Young People’s Diabetes Team at Leeds Children’s Hospital, alongside individuals transitioning through the Trust’s Young Adults Diabetes Service, will be offered voluntary enrollment into the digital testing program. Rather than relying solely on traditional periodic outpatient clinic visits, the program introduces specialized platforms to build a continuous “hybrid” care model.

The clinical teams will specifically deploy and assess Diabeter’s CloudCare platform alongside DigiBete’s dedicated patient engagement and video-based educational apps.

This combination will allow continuous data harvesting regarding glucose tracking, insulin administration patterns, and real-time patient compliance, which can be monitored remotely by specialist practitioners.

What Do Clinical and Industry Leaders Say About the Collaboration?

The integration of clinical expertise and third-party digital infrastructure has drawn strong support from the leading organizers of the UK arm of the trial.

As reported by the editorial staff of Digital Health, Dr Fiona Campbell, clinical lead of the Children and Young People’s Diabetes Team at Leeds Teaching Hospitals NHS Trust, stated that the team is

“very excited to be involved in this major European initiative together with our partners Minimed Diabeter and DigiBete.”

Dr Campbell expanded on the scope of the project, noting:

“This will allow the diabetes team at Leeds Children’s Hospital to explore how remote monitoring and personalised digital education can improve treatment, self-management and quality of care among children, adolescents and young adults living with type 1 diabetes. As one of the UK’s largest specialist children’s hospitals, we have one of the most comprehensive paediatric diabetes services in the country. This new initiative is a significant step forward in collaborating to bring clinical expertise, digital infrastructure, and patient-centred education together to help improve treatment and care for our young patients and also contribute to the adoption of technologies across Europe.”

Simultaneously, the industrial partners responsible for the software platforms emphasized the shift toward personalized medicine. As documented in the official IMPACT-MED program declarations, Maarten Akkerman, chairman of the board at Diabeter, stated:

“With Leeds Teaching Hospitals and Digibete’s pioneering efforts in digital training and education combined with Diabeter’s remote monitoring driven population management innovation, we are making the next step towards a hybrid care setting while not losing the individual patient needs out of sight and being able to address those even better.”

Background of This Particular Development

The selection of Leeds as a core research site comes amid a concerted, multi-year push by the NHS to adopt digital health technologies to address severe staffing shortages and rising clinic waiting lists. Over the last several years, the UK government has systematically allocated funding—including multi-million-pound digital infrastructure grants to various regional trusts—to upgrade baseline hospital network capabilities to support secure, high-bandwidth data transmission required for remote patient monitoring.

Paediatric Type 1 diabetes care has historically been highly reliant on intensive face-to-face consultations, manual logging of blood sugar levels, and heavily structured family education sessions.

The integration of specialized digital training resources like DigiBete, which emerged as an approved educational resource during past NHS accessibility expansions, laid the groundwork for this international pilot.

By aligning with Diabeter, an innovative clinic model initially founded in the Netherlands that utilizes data-driven population management, the Leeds Trust is building upon a pre-existing national strategy to move chronic disease management away from hospital beds and directly into patients’ daily lives.

Explore More Local Leeds News

Major Bus Diversions as Key Roads Close in Leeds 2026

River Aire Centenary Bridge Restored For Leeds 400: Leeds City Centre 2026

Prediction: How This Development Can Affect Young Diabetes Patients and Their Families

The successful execution of the IMPACT-MED pilot in Leeds is highly likely to reshape the daily routines, independence levels, and clinical safety nets for young diabetes patients and their care networks across the United Kingdom.

For the specific audience of young patients and their parents, the widespread adoption of remote monitoring through systems like CloudCare means a projected decrease in the frequency of mandatory, disruptive in-person hospital check-ups.

Instead of taking time off school or work to travel to Leeds Children’s Hospital for routine data downloads, families can transmit metabolic profiles seamlessly from home.

This shift allows clinical teams to review data asynchronously, keeping physical appointments reserved primarily for complex cases or acute care adjustments.

Adolescents and young adults face a historically high risk of glycemic instability as they transition away from parental oversight toward independent self-care.

The availability of personalized, on-demand digital education modules provides this age group with immediate, peer-vetted problem-solving tools directly on their smartphones.

This accessibility is predicted to minimize common management errors related to carbohydrate counting or insulin dosing adjustments during exercise and illness, potentially lowering the incidence of severe hypoglycemia and diabetic ketoacidosis (DKA) admissions.

As a standardized European pilot site, the data generated in Leeds will serve as a direct benchmark for the National Institute for Health and Care Excellence (NICE) and NHS England.

If the pilot demonstrates measurable stabilization in patient HbA1c levels and high satisfaction rates among the 500 participating Yorkshire youth, it will likely accelerate the formal commissioning and funding of these identical hybrid tools across the remaining paediatric diabetes units throughout the UK, establishing a new national baseline for digital-first chronic care.